Atlas Trials

DARA RVD For High Risk SMM

Clinical trial NCT04775550 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04775550
Sponsor
Omar Nadeem, MD
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
High-risk Smoldering Multiple MyelomaMultiple Myeloma
Start date
2021-03-08
Primary completion
2027-12-20
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.